Is Goodrx Holdings Stock a Good Investment?
Goodrx Holdings Investment Advice | GDRX |
- Examine Goodrx Holdings' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Goodrx Holdings' leadership team and their track record. Good management can help Goodrx Holdings navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Technology space and any emerging trends that could impact Goodrx Holdings' business and its evolving consumer preferences.
- Compare Goodrx Holdings' performance and market position to its competitors. Analyze how Goodrx Holdings is positioned in terms of product offerings, innovation, and market share.
- Check if Goodrx Holdings pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Goodrx Holdings' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Goodrx Holdings stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Goodrx Holdings is a good investment.
Sell | Buy |
Hold
Market Performance | Very Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Goodrx Holdings Stock
Researching Goodrx Holdings' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 71.0% of the company shares are owned by institutional investors. The book value of Goodrx Holdings was currently reported as 1.83. The company has Price/Earnings To Growth (PEG) ratio of 1.98. Goodrx Holdings recorded a loss per share of 0.04. The entity had not issued any dividends in recent years.
To determine if Goodrx Holdings is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Goodrx Holdings' research are outlined below:
| Goodrx Holdings generated a negative expected return over the last 90 days | |
| Goodrx Holdings has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 750.26 M. Net Loss for the year was (8.87 M) with profit before overhead, payroll, taxes, and interest of 701.48 M. | |
| Goodrx Holdings has a strong financial position based on the latest SEC filings | |
| About 71.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Barclays Cuts GoodRx Price Target to 6.00 |
Goodrx Holdings Quarterly Cash And Short Term Investments |
|
Goodrx Holdings uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Goodrx Holdings. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Goodrx Holdings' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Goodrx Holdings' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Goodrx Holdings' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-07 | 2024-09-30 | 0.09 | 0.08 | -0.01 | 11 | ||
2024-08-08 | 2024-06-30 | 0.09 | 0.08 | -0.01 | 11 | ||
2024-02-29 | 2023-12-31 | 0.07 | 0.08 | 0.01 | 14 | ||
2023-08-09 | 2023-06-30 | 0.06 | 0.07 | 0.01 | 16 | ||
2023-05-10 | 2023-03-31 | 0.06 | 0.07 | 0.01 | 16 | ||
2022-02-28 | 2021-12-31 | 0.1 | 0.09 | -0.01 | 10 | ||
2021-03-11 | 2020-12-31 | 0.07 | 0.08 | 0.01 | 14 | ||
2020-11-12 | 2020-09-30 | 0.08 | 0.09 | 0.01 | 12 |
Know Goodrx Holdings' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Goodrx Holdings is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Goodrx Holdings backward and forwards among themselves. Goodrx Holdings' institutional investor refers to the entity that pools money to purchase Goodrx Holdings' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Rip Road Capital Partners Lp | 2024-06-30 | 2.2 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 2 M | Blackrock Inc | 2024-06-30 | 1.7 M | Technology Crossover Management X, Ltd. | 2024-09-30 | 1.7 M | Point72 Asset Management, L.p. | 2024-09-30 | 1.6 M | Dimensional Fund Advisors, Inc. | 2024-09-30 | 1.6 M | State Street Corp | 2024-06-30 | 1.1 M | Connor Clark & Lunn Inv Mgmt Ltd | 2024-06-30 | 1 M | Geode Capital Management, Llc | 2024-09-30 | 982.7 K | Francisco Partners Management Lp | 2024-09-30 | 70.1 M | Vanguard Group Inc | 2024-09-30 | 7.9 M |
Goodrx Holdings' market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.87 B.Market Cap |
|
Goodrx Holdings' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.01) | (0.01) | |
| Return On Equity | (0.01) | (0.01) |
Determining Goodrx Holdings' profitability involves analyzing its financial statements and using various financial metrics to determine if Goodrx Holdings is a good buy. For example, gross profit margin measures Goodrx Holdings' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Goodrx Holdings' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Goodrx Holdings' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Goodrx Holdings. Check Goodrx Holdings' Beneish M Score to see the likelihood of Goodrx Holdings' management manipulating its earnings.
Evaluate Goodrx Holdings' management efficiency
Goodrx Holdings has return on total asset (ROA) of 0.0421 % which means that it generated a profit of $0.0421 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0206) %, meaning that it created substantial loss on money invested by shareholders. Goodrx Holdings' management efficiency ratios could be used to measure how well Goodrx Holdings manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.0082 in 2024. Return On Capital Employed is likely to rise to -0.02 in 2024. At this time, Goodrx Holdings' Net Tangible Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 23.9 M in 2024, whereas Total Assets are likely to drop slightly above 1.3 B in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.86 | 1.95 | |
| Tangible Book Value Per Share | 0.47 | 0.50 | |
| Enterprise Value Over EBITDA | 25.62 | 24.34 | |
| Price Book Value Ratio | 3.61 | 3.43 | |
| Enterprise Value Multiple | 25.62 | 24.34 | |
| Price Fair Value | 3.61 | 3.43 | |
| Enterprise Value | 14 B | 12.4 B |
The strategic initiatives led by Goodrx Holdings' management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Beta 1.393 |
Basic technical analysis of Goodrx Stock
As of the 25th of November, Goodrx Holdings retains the Market Risk Adjusted Performance of (0.31), risk adjusted performance of (0.11), and Standard Deviation of 3.84. Goodrx Holdings technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Goodrx Holdings' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Goodrx Holdings insiders, such as employees or executives, is commonly permitted as long as it does not rely on Goodrx Holdings' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Goodrx Holdings insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Goodrx Holdings' Outstanding Corporate Bonds
Goodrx Holdings issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Goodrx Holdings uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Goodrx bonds can be classified according to their maturity, which is the date when Goodrx Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Understand Goodrx Holdings' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Goodrx Holdings' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | (0.31) | |||
| Mean Deviation | 2.32 | |||
| Coefficient Of Variation | (661.26) | |||
| Standard Deviation | 3.84 | |||
| Variance | 14.74 | |||
| Information Ratio | (0.19) | |||
| Jensen Alpha | (0.81) | |||
| Total Risk Alpha | (1.20) | |||
| Treynor Ratio | (0.32) | |||
| Maximum Drawdown | 26.37 | |||
| Value At Risk | (4.74) | |||
| Potential Upside | 3.07 | |||
| Skewness | (0.38) | |||
| Kurtosis | 8.28 |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | (0.31) | |||
| Mean Deviation | 2.32 | |||
| Coefficient Of Variation | (661.26) | |||
| Standard Deviation | 3.84 | |||
| Variance | 14.74 | |||
| Information Ratio | (0.19) | |||
| Jensen Alpha | (0.81) | |||
| Total Risk Alpha | (1.20) | |||
| Treynor Ratio | (0.32) | |||
| Maximum Drawdown | 26.37 | |||
| Value At Risk | (4.74) | |||
| Potential Upside | 3.07 | |||
| Skewness | (0.38) | |||
| Kurtosis | 8.28 |
Consider Goodrx Holdings' intraday indicators
Goodrx Holdings intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Goodrx Holdings stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Goodrx Holdings Corporate Filings
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 18th of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 10th of October 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
Goodrx Stock media impact
Far too much social signal, news, headlines, and media speculation about Goodrx Holdings that are available to investors today. That information is available publicly through Goodrx media outlets and privately through word of mouth or via Goodrx internal channels. However, regardless of the origin, that massive amount of Goodrx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Goodrx Holdings news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Goodrx Holdings relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Goodrx Holdings' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Goodrx Holdings alpha.
Goodrx Holdings Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Goodrx Holdings can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Goodrx Holdings Historical Investor Sentiment
Investor biases related to Goodrx Holdings' public news can be used to forecast risks associated with an investment in Goodrx. The trend in average sentiment can be used to explain how an investor holding Goodrx can time the market purely based on public headlines and social activities around Goodrx Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Goodrx Holdings' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Goodrx Holdings and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Goodrx Holdings news discussions. The higher the estimate score, the more favorable the investor's outlook on Goodrx Holdings.
Goodrx Holdings Corporate Management
| Douglas Hirsch | CoCEO Cofounder | Profile | |
| Andrew Slutsky | Chief Officer | Profile | |
| Nitin Shingate | Chief Officer | Profile | |
| Babak Azad | Chief Communications | Profile | |
| Whitney Notaro | Vice Relations | Profile |
Additional Tools for Goodrx Stock Analysis
When running Goodrx Holdings' price analysis, check to measure Goodrx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Goodrx Holdings is operating at the current time. Most of Goodrx Holdings' value examination focuses on studying past and present price action to predict the probability of Goodrx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Goodrx Holdings' price. Additionally, you may evaluate how the addition of Goodrx Holdings to your portfolios can decrease your overall portfolio volatility.